Abeona Therapeutics
(NASDAQ) ABEO
Abeona Therapeutics Financials at a Glance
Market Cap
$319.74M
Revenue (TTM)
$14.54M
Net Income (TTM)
$66.14M
EPS (TTM)
$0.94
P/E Ratio
5.99
Dividend
$0.00
Beta (Volatility)
0.95 (Low)
Dividend
$0.00
Beta (Volatility)
0.95 (Low)
Price
$5.61
Volume
23,367
Open
$5.57
Price
$5.61
Volume
23,367
Open
$5.57
Previous Close
$5.61
Daily Range
$5.52 - $5.65
52-Week Range
$4.00 - $7.54
Estimated Earnings Date
Aug 13, 2026
Dividend
$0.00
Beta (Volatility)
0.95 (Low)
Price
$5.61
Volume
23,367
Open
$5.57
Previous Close
$5.61
Daily Range
$5.52 - $5.65
52-Week Range
$4.00 - $7.54
Estimated Earnings Date
Aug 13, 2026
ABEO News
ABEO: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Abeona Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
226
CEO
Vishwas Seshadri, PhD, MBA
Website
www.abeonatherapeutics.comHeadquarters
Cleveland, NY 10019, US
ABEO Financials
Key Financial Metrics (TTM)
Gross Margin
51.93%
Operating Margin
-637.92%
Net Income Margin
454.86%
Return on Equity
41.40%
Return on Capital
-48.56%
Return on Assets
33.32%
Earnings Yield
16.69%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$319.74M
Shares Outstanding
57.00M
Volume
23.37K
Avg. Volume
1.11M
Financials (TTM)
Gross Profit
$7.55M
Operating Income
-$92.75M
EBITDA
$73.43M
Operating Cash Flow
-$77.73M
Capital Expenditure
-$7.51M
Free Cash Flow
-$85.24M
Cash & ST Invst.
$168.27M
Total Debt
$23.17M
Abeona Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$8.72M
N/A
Gross Profit
$5.16M
N/A
Gross Margin
59.12%
N/A
Market Cap
$319.74M
N/A
Market Cap/Employee
$2.35M
N/A
Employees
136
N/A
Net Income
-$17.08M
-41.9%
EBITDA
-$15.37M
-50.5%
Quarterly Fundamentals
Total Cash
$168.27M
+100.0%
Total Debt
$23.17M
-3.4%
Accounts Receivable
$6.71M
+314.9%
Inventory
$6.05M
N/A
Long Term Debt
$8.57M
-43.7%
Short Term Debt
$14.61M
+66.7%
Return on Assets
33.32%
N/A
Return on Invested Capital
-55.39%
N/A
Free Cash Flow
-$20.74M
-4.7%
Operating Cash Flow
-$19.80M
-7.6%